


Level 42 AI
Medical Equipment Manufacturing • Mountain View, California, United States • 11-20 Employees
Company overview
| Headquarters | Mountain View, California, United States |
| Phone number | +16505156112 |
| Website | |
| NAICS | 3391 |
| Founded | 2019 |
| Employees | 11-20 |
| Socials |
Key Contacts at Level 42 AI
Shasha Jumbe
Co-Founder, Ceo
Peter Rexelius
Co-Founder
Andreas Schuh
Co-Founder
Michael Morimoto
Co-Founder
Level 42 AI Email Formats
Level 42 AI uses 1 email format. The most common is {first initial} (e.g., j@level42.ai), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@level42.ai | 100% |
About Level 42 AI
Silicon Valley startup, Level 42 AI, Inc’s software-defined hardware captures and synchronizes traditionally discarded or unobserved multi-modal data streams to predict and quantify health state, from short 5-to-30 second data snippets, similar in principle to the music identification Shazam app. UNMET NEED: In addition to the ‘classic‘ COVID-19 illness, COVID-19-associated multi-system inflammatory syndrome in children (MIS-C) has recently emerged as a complicated and potentially fatal outcome resulting in school and workplace closures. The world needs a fast, accurate, non-invasive, affordable mass screening test for COVID-19; such a test should safely manage entry to workplaces, airplanes, schools, stadiums, theaters, mass transit center, ports-of-entry, malls and restaurants. Level 42 AI, Inc is conducting clinical studies to discover and validate COVID-19 biosignatures with Johns Hopkins School of Medicine (JHM) and University of California-San Francisco (UCSF). The mass screening technology has the potential to detect and screen individuals and patients with COVID-19 remotely, from a distance, using non-invasive, non-intrusive, and non-contact technology. Accurate and rapid COVID-19 mass screening is complementary to vaccine development and deployment. Level 42 AI, Inc’s COVID-19 biosignature is an AI algorithm that deploys state-of-the-art, proprietary domain-adaptable machine learning techniques to elucidate and differentiate early cellular and tissue mechano-transduction changes and the body's immune response to SARS-CoV-2 infection. By combining and analyzing multiple synchronized data streams, Level 42 AI, Inc aims to unveil robust and distinct biosignatures for actionable insights on the symptoms and onset of COVID-19, MIS-C, asthma, COPD, cystic fibrosis, TB, pulmonary arterial hypertension, acute respiratory distress syndrome, carotid artery disease, coronary artery disease, congestive heart failure, pain, depression, more
Level 42 AI revenue & valuation
| Annual revenue | $1,283,325 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $4,200,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Level 42 AI has 7 employees across 4 departments.
Departments
Number of employees
Funding Data
Level 42 AI has never raised funding before.
Level 42 AI Tech Stack
Discover the technologies and tools that power Level 42 AI's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Databases
Tag managers
Reverse proxies
Programming languages
Hosting
Miscellaneous
Blogs
SEO
Analytics
Analytics
Frequently asked questions
4.8
40,000 users



